Re: Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients with Muscle-invasive Urothelial Bladder Carcinoma (PURE-01): An Open-label, Single-arm, Phase II Study. Article uri icon

Overview

publication date

  • January 8, 2019

Research

keywords

  • Carcinoma, Transitional Cell
  • Urinary Bladder Neoplasms

Identity

Scopus Document Identifier

  • 85059511474

Digital Object Identifier (DOI)

  • 10.1016/j.eururo.2018.12.034

PubMed ID

  • 30630644

Additional Document Info

volume

  • 75

issue

  • 4